Related Experiment Videos

[Review of management guidelines. 1. Pneumonia]

Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine

|November 28, 2002

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Efficacy and safety of isavuconazole against deep-seated mycoses: A phase 3, randomized, open-label study in Japan.

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy·2022

All-cause mortality rates in adults with carbapenem-resistant Gram-negative bacterial infections: a comprehensive review of pathogen-focused, prospective, randomized, interventional clinical studies.

Expert review of anti-infective therapy·2021

Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trial.

The Lancet. Infectious diseases·2020

Nationwide surveillance of bacterial respiratory pathogens conducted by the surveillance committee of japanese society of chemotherapy, the japanese association for infectious diseases, and the japanese society for clinical microbiology in 2016: General view of the pathogens' antibacterial susceptibility.

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy·2020

Candidatus Mycoplasma haemohominis in Human, Japan.

Emerging infectious diseases·2019

Daily practice and prognostic factors for pneumonia caused by methicillin-resistant Staphylococcus aureus in Japan: A multicenter prospective observational cohort study.

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy·2019

See all related articles